Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations

Medicine, Oncology, Pharmacotherapy +13

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

Israel Ringel, Susan Band Horwitz · JNCI Journal of the National Cancer Institute · 1991 · 674 citations

Medicine, Oncology, Pharmacology +15

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 633 citations

Medicine, Oncology, Pharmacology +11

Relationships between the structure of taxol analogs and their antimitotic activity

Françoise Guéritte-Voegelein, Daniel Guénard, François Lavelle et al. · Journal of Medicinal Chemistry · 1991 · 537 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

Marie-Christine Bissery, Daniel Guénard, Françoise Guéritte-Voegelein et al. · PubMed · 1991 · 481 citations

Medicine, Oncology, Pharmacology +12